Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrence of Malignant Neoplasm of Prostate”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Not applicableStudy completedNCT04318028
What this trial is testing

An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Non-Metastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+7 more
University of Southern California 20
Large-scale testing (Phase 3)Ended earlyNCT05744115
What this trial is testing

Ga-68-PSMA-11 in Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Timothy Hoffman 38
Not applicableUnknownNCT05048537
What this trial is testing

18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.

Who this might be right for
Biochemical Relapse Fo Malignant Neoplasm of Prostate
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Large-scale testing (Phase 3)Study completedNCT06235099
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate
Curium US LLC 235
Large-scale testing (Phase 3)Study completedNCT00925600
What this trial is testing

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Who this might be right for
CancerCataractLow Bone Mineral Density+3 more
Amgen 769
Testing effectiveness (Phase 2)Active Not RecruitingNCT04335682
What this trial is testing

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Who this might be right for
Metastatic Prostate CancerProstate Cancer MetastaticProstate Cancer+3 more
Alliance Foundation Trials, LLC. 111
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Not applicableNot Yet RecruitingNCT06875297
What this trial is testing

A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 184
Early research (Phase 1)Active Not RecruitingNCT06105918
What this trial is testing

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
Emory University 6
Not applicableLooking for participantsNCT06859203
What this trial is testing

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Technical University of Munich 94
Testing effectiveness (Phase 2)Looking for participantsNCT07365423
What this trial is testing

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

Who this might be right for
Recurrent Prostate Cancer
Swiss Cancer Institute 42
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Testing effectiveness (Phase 2)Study completedNCT05249127
What this trial is testing

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 52
Early research (Phase 1)Active Not RecruitingNCT05617885
What this trial is testing

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Who this might be right for
Metastatic Prostate CancerNon-metastatic Prostate CancerProstate Cancer
Praful Ravi, MB BCHir, MRCP 9
Not applicableLooking for participantsNCT05123391
What this trial is testing

Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmsRadiosurgeryQuality of Life
Pontificia Universidad Catolica de Chile 60
Not applicableLooking for participantsNCT06202248
What this trial is testing

Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

Who this might be right for
Non-metastatic Prostate CancerLocally Recurrent Prostate Cancer
Alpha Tau Medical LTD. 10
Not applicableLooking for participantsNCT06468332
What this trial is testing

Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer

Who this might be right for
Prostate Cancer
Azienda Ospedaliero Universitaria Maggiore della Carita 400
Testing effectiveness (Phase 2)Study completedNCT05407311
What this trial is testing

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 53
Early research (Phase 1)Study completedNCT04978675
What this trial is testing

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaProstate Adenocarcinoma
M.D. Anderson Cancer Center 29
Load More Results